Table 3 Relationship between the severity of CAD in MI patients and various risk factors.

From: The correlation between the atherogenic index of plasma and the severity of coronary artery disease in acute myocardial infarction patients under different glucose metabolic states

Variables

Multi-vessel CAD

 

OR(95%CI)

β

P-value

Age

1.016(1.002–1.030)

0.016

0.022

Sex

   

Male

Reference

  

Female

1.269 (0.855–1.884)

0.239

0.236

BMI

0.972 (0.924–1.022)

−0.028

0.265

Smoking

   

No

Reference

  

Yes

0.941 (0.672–1.319)

−0.060

0.725

Drinking

   

No

Reference

  

Yes

0.728 (0.487–1.090)

−0.317

0.123

Hypertension

   

No

Reference

  

Yes

0.960(0.683–1.350)

−0.041

0.815

CHD

   

No

Reference

  

Yes

0.621(0.419–0.920)

−0.477

0.018

SBP

1.003 (0.995–1.010)

0.003

0.477

DBP

0.997 (0.986–1.009)

−0.003

0.664

HbA1c

1.173 (1.034–1.329)

0.159

0.013

TC

1.141 (0.973–1.338)

0.132

0.104

TG

1.080 (0.959–1.218)

0.077

0.204

HDL-C

0.634 (0.343–1.172)

−0.455

0.146

LDL-C

1.087 (0.91–1.298)

0.083

0.357

Hb

0.997 (0.989–1.005)

−0.003

0.432

Plt

1.001 (0.999–1.004)

0.001

0.314

eGFR

1.000(0.999–1.000)

0

0.657

LAD

1.015 (0.981–1.051)

0.015

0.390

LVDd

1.016 (0.988–1.046)

0.016

0.268

LVEF

0.985 (0.968–1.001)

−0.015

0.074

AIP

2.055 (1.189–3.550)

0.720

0.009

  1. CAD coronary artery disease, MI myocardial infarction, BMI body mass index, CHD coronary heart disease, SBP systolic blood pressure, DBP diastolic blood pressure, HbA1c glycated hemoglobin, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Hb hemoglobin, Plt platelet count, eGFR estimated glomerular filtration rate, LAD left atrial diameter, LVDd left ventricular end-diastolic diameter, LVEF, left ventricular ejection fraction, AIP atherogenic index of plasma.